Robert J. Edwards

International Vaccine Institute — South Korea

Medicine · Health Sciences

51h-index8.4kcitations222works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(43), HIV Research and Treatment(37), Pharmacogenetics and Drug Metabolism(34), Cardiomyopathy and Myosin Studies(29), Monoclonal and Polyclonal Antibodies Research(22)

Publications221 total

Presentation of hemagglutinin on adjuvant-bearing self-assembling peptide nanofibers increases heterologous responses against influenza
Acta Biomaterialia·2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity
Journal of Virology·2025Open Access
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Cell·2025Open Access
Mechanisms of early-life immunity associated with induction of heterologous HIV-1 neutralizing antibodies 9283
The Journal of Immunology·2025Open Access
A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization
UNC Libraries·2025Open Access
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates
Science Translational Medicine·2025· 1 cited
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domain
2025Open Access
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development
2025· 8 citedOpen Access
Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus
Mucosal Immunology·2025· 7 citedOpen Access
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity
2025Open Access
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutations
Science Translational Medicine·2025· 3 cited
Mechanistic and Antigenic Boundaries of <i>Henipavirus</i> and <i>Parahenipavirus</i> Glycoproteins
2024Open Access
Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques
Nature Communications·2024· 2 citedOpen Access
Anti-HIV-1 B cell antigen receptor signaling and structure
2024Open Access
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families
PLoS Pathogens·2024· 6 citedOpen Access
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition
Molecular Cell·2024· 20 citedOpen Access
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
PLoS Pathogens·2024· 27 citedOpen Access
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Cell·2024· 37 citedOpen Access
Comparison of Two Different Alfaxalone Concentrations Combined with Midazolam to Anesthetize Cynomolgus Macaques (Macaca fascicularis) for Plethysmography
Comparative Medicine·2024Open Access
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals
2024· 6 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Barton F. Haynes(21), Priyamvada Acharya(20), Katayoun Mansouri(18), Kevin O. Saunders(17), David C. Montefiori(16), Rory Henderson(15), S. Gobeil(15), Katarzyna Janowska(13), Victoria Stalls(13), Kevin Wiehe(13), Robert Parks(12), S. Munir Alam(11), Megan Kopp(10), Kartik Manne(10), Alan R. Boobis(10), Gregory D. Sempowski(9), Maggie Barr(8), Amanda Eaton(8), Allen L. Hsu(7), Mario J. Borgnia(7)